Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

Kristian Kofoed; Uffe Vest Schneider; Troels Scheel; Ove Andersen; Jesper Eugen-Olsen

doi:http://dx.doi.org/10.1373/clinchem.2006.067595

Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

Kristian Kofoed, Uffe Vest Schneider, Troels Scheel, Ove Andersen, Jesper Eugen-Olsen

Bachelor- og kandidatuddannelser

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › peer review

117 Citationer (Scopus)

Abstract

Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

Originalsprog	Engelsk
Tidsskrift	Clinical Chemistry
Vol/bind	52
Udgave nummer	7
Sider (fra-til)	1284-93
Antal sider	10
ISSN	0009-9147
DOI	https://doi.org/10.1373/clinchem.2006.067595
Status	Udgivet - 2006

Adgang til dokumentet

http://dx.doi.org/10.1373/clinchem.2006.067595

Citationsformater

@article{3d4ad2bb03084576894d5811177397cd,

title = "Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology",

abstract = "Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.",

author = "Kristian Kofoed and Schneider, {Uffe Vest} and Troels Scheel and Ove Andersen and Jesper Eugen-Olsen",

year = "2006",

doi = "http://dx.doi.org/10.1373/clinchem.2006.067595",

language = "English",

volume = "52",

pages = "1284--93",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry, Inc.",

number = "7",

}

TY - JOUR

T1 - Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

AU - Kofoed, Kristian

AU - Schneider, Uffe Vest

AU - Scheel, Troels

AU - Andersen, Ove

AU - Eugen-Olsen, Jesper

PY - 2006

Y1 - 2006

N2 - Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

AB - Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

U2 - http://dx.doi.org/10.1373/clinchem.2006.067595

DO - http://dx.doi.org/10.1373/clinchem.2006.067595

M3 - Journal article

VL - 52

SP - 1284

EP - 1293

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 7

ER -